Okładka

Evaluation of serum zinc level in patients with Alopecia Areata

Background: Alopecia areata (AA) is non-scarring telogenic alopecia of autoimmune etiology. Clinically, the disease is characterized by the appearance of alopecic patches or plaques of varying size and number on the scalp with peak incidence 2% in the general population, can involve any age group wi...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Ivan Abdullah (Autor), Sangar Othman (Autor)
Format:	Książka
Wydane:	University of Mosul, 2022-07-01T00:00:00Z.
Hasła przedmiotowe:	article
Dostęp online:	Connect to this object online.
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Serum Zinc Concentration in Patients with Alopecia Areata
od: Jovan Lalosevic, i wsp.
Wydane: (2023)

ROLE OF SERUM ZINC AND COPPER AND ZINC/ COPPER RATIO IN ALOPECIA AREATA
od: Ashwaq Najjem Elldin Al- Jaff
Wydane: (2017)

ROLE OF SERUM ZINC AND COPPER AND ZINC/ COPPER RATIO IN ALOPECIA AREATA
od: Ashwaq Najjem Elldin Al- Jaff
Wydane: (2017)

Serum Vitamin D in patients with alopecia areata
od: Ola Ahmed Bakry, i wsp.
Wydane: (2016)

Total serum immunoglobulin E in patients with alopecia areata
od: Ola Ahmed Bakry, i wsp.
Wydane: (2014)

Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients
od: Icim Komurcugil, i wsp.
Wydane: (2024)

Adiponectin serum levels and ADIPOQ (rs2241766) polymorphism in alopecia areata Egyptian patients
od: Azza Gaber Antar Farag, i wsp.
Wydane: (2024)

Evaluation of the quality of life in patients with alopecia areata and androgenetic alopecia
od: I. N. Kondrakhina, i wsp.
Wydane: (2017)

Evaluation of serum homocysteine, high-sensitivity CRP, and RBC folate in patients with alopecia areata
od: Maryam Yousefi, i wsp.
Wydane: (2014)

Vitamin D level in alopecia areata
od: Yasmeen Jabeen Bhat, i wsp.
Wydane: (2017)

Increase in IL-15 levels in patients with alopecia areata
od: Dominika Katarzyna Madras, i wsp.
Wydane: (2020)

Alopecia areata
od: Chieh Chen
Wydane: (2023)

Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
od: Emina Kasumagić-Halilovic, i wsp.
Wydane: (2012)

Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
od: Agatha Anindhita Ayu Ardhaninggar, i wsp.
Wydane: (2018)

Alopecia areata: revisão e atualização Alopecia areata: a revision and update
od: Evandro A. Rivitti
Wydane: (2005)

Evaluation of clinical significance of dermoscopy in alopecia areata
od: Akhila Sai Guttikonda, i wsp.
Wydane: (2016)

Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
od: Muzeyyen Gonul, i wsp.
Wydane: (2018)

Critical comment on "Vitamin D level in alopecia areata"
od: Radha Saini, i wsp.
Wydane: (2018)

Evaluation of oxidative stress indicators in lymphocytes of patients with alopecia areata
od: AL-Gaff A.N, i wsp.
Wydane: (2005)

Perinevoid alopecia: an unusual presentation of alopecia areata
od: Jose Leonardo Rodrigues Machado, i wsp.
Wydane: (2022)

Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
od: Trang Le Thi Thuy, i wsp.
Wydane: (2021)

Alopecia areata difficult case
od: Anca Chiriac, i wsp.
Wydane: (2012)

Alopecia Areata With Folliculitis Decalvans
od: Kumar Kailash, i wsp.
Wydane: (1997)

Utility of dermoscopy in alopecia areata
od: Mandar Mane, i wsp.
Wydane: (2011)

Alopecia areata, morphea and psoriasis
od: Koray Durmaz, i wsp.
Wydane: (2020)

Psychological Impact of Alopecia Areata
od: Suchana Marahatta, i wsp.
Wydane: (2020)

Trichoscopy in alopecia areata and trichotillomania
od: Saurabh Sharma, i wsp.
Wydane: (2023)

Alopecia areata: medical treatments
od: Zonunsanga
Wydane: (2015)

Alopecia areata: Update on management
od: Julie S Kranseler, i wsp.
Wydane: (2017)

Serum CCL20: A novel potential marker of cardiovascular risk in alopecia areata patients
od: Ahmed M Hamed, i wsp.
Wydane: (2023)

Comparison of Zn, Cu, and Fe Content in Hair and Serum in Alopecia Areata Patients with Normal Group
od: Ladan Dastgheib, i wsp.
Wydane: (2014)

Comorbidities and associated factors in patients with alopecia areata
od: Ana Lucía Jacas Portuondo, i wsp.
Wydane: (2022)

Dietary Habits in Japanese Patients with Alopecia Areata
od: Hagino T, i wsp.
Wydane: (2021)

Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
od: Bewley A, i wsp.
Wydane: (2024)

Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
od: Ramírez-Marín HA, i wsp.
Wydane: (2022)

Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
od: Ernest H. Law, i wsp.
Wydane: (2024)

Estimation of zinc and iron levels in the serum and hair of women with androgenetic alopecia: Case-control study
od: Samer A Dhaher, i wsp.
Wydane: (2018)

Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata,
od: Özge Aşkın, i wsp.
Wydane: (2021)

Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional studyCapsule Summary
od: Felix Paolo J. Lizarondo, MD, i wsp.
Wydane: (2021)

Alopecia areata after mogamulizumab treatment
od: Neel S. Raval, BS, MPHS, i wsp.
Wydane: (2022)